XPENG Reports Significant Q1 2026 Net Loss and Revenue Decline, Guides for Strong Q2 Recovery
Summary
XPENG reported a significant net loss and declines in revenue and deliveries for Q1 2026, but showed improved gross margins and issued strong guidance for a sequential recovery in Q2 2026.
Key Events
-
Q1 2026 Net Loss Reported
XPENG reported a net loss of RMB1.78 billion (US$0.26 billion) for Q1 2026, a significant swing from a profit of RMB0.38 billion in Q4 2025 and an increased loss from RMB0.66 billion in Q1 2025.
-
Revenue and Deliveries Decline
Total revenues decreased 17.6% year-over-year and 41.4% quarter-over-quarter to RMB13.03 billion (US$1.89 billion). Vehicle deliveries fell 33.3% year-over-year to 62,682 units.
-
Gross Margin Improvement
Gross margin increased to 20.6% in Q1 2026, up 5.0 percentage points from 15.6% in Q1 2025, indicating improved cost efficiency or product mix despite lower sales volume.
-
Strong Q2 2026 Guidance
The company expects Q2 2026 vehicle deliveries between 100,000 and 106,000 units, representing a 59.5% to 69.1% sequential increase. Total revenues are projected to be between RMB19.60 billion and RMB20.80 billion, a 50.4% to 59.6% sequential increase.
Analysis
XPENG reported a substantial net loss of RMB1.78 billion (US$0.26 billion) for Q1 2026, a significant reversal from the RMB0.38 billion profit in Q4 2025. Total revenues decreased by 17.6% year-over-year and 41.4% quarter-over-quarter, with vehicle deliveries also falling sharply. This indicates a challenging start to the year for the company. However, gross margin improved significantly year-over-year to 20.6%, and the company provided strong Q2 2026 guidance, projecting a substantial sequential increase in both deliveries (59.5% to 69.1%) and total revenues (50.4% to 59.6%). This suggests management anticipates a strong rebound after the Q1 slowdown, potentially driven by new model launches like the XPENG GX.
At the time of this filing, XPEV was trading at $16.61 on NYSE in the Manufacturing sector, with a market capitalization of approximately $15.3B. The 52-week trading range was $14.72 to $28.24. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.